Trade AbbVie ^ABBV

AbbVie (ABBV) Announces European Commission's Approval of AQUIPTA®

AbbVie (NYSE:ABBV) Trading 1.2% Higher - What's Next? - Daily Political

Pharmaceutical Stocks To Consider - June 5th - Stock Observer

AbbVie Inc. $ABBV Shares Purchased by Westfield Capital Management Co. LP

Vise Technologies Inc. Acquires 25,198 Shares of AbbVie Inc. $ABBV

WCG Wealth Advisors LLC Buys Shares of 17,087 AbbVie Inc. $ABBV

12,757 Shares in AbbVie Inc. $ABBV Bought by Total Wealth Planning & Management Inc.

J.W. Cole Advisors Inc. Cuts Stake in AbbVie Inc. $ABBV

AbbVie Inc. $ABBV Shares Bought by Prestige Wealth Management Group LLC - Stock Observer

AbbVie (NYSE:ABBV) Shares Unloaded Rep. Josh Gottheimer

Clifford Swan Investment Counsel LLC Sells 3,532 Shares of AbbVie Inc. $ABBV - Stock Observer

AbbVie (NYSE:ABBV) Stock Unloaded Rep. Josh Gottheimer - Stock Observer

NICE Endorses AbbVie's Elahere for Treating Ovarian Cancer, ETPharma

Elahere's NHS Approval Tests AbbVie's Oncology Expansion And Investor Thesis

AbbVie (NYSE:ABBV) Shares Up 3.5% - Here's What Happened

Aldeyra Therapeutics Eyes FDA Feedback as Dry Eye Drug Faces Make-or-Break Moment - Stock Observer

5 Best Cheap Stocks to Buy for Beginners

Greenspring Advisors LLC Grows Stake in AbbVie Inc. $ABBV

AbbVie Inc. $ABBV Shares Sold by TD Asset Management Inc

Top Medical Stocks To Research - June 4th - Daily Political

AbbVie Inc. $ABBV Shares Bought by Cibc World Market Inc.

Promising Medical Stocks To Research - June 3rd - Zolmax

Bank of New York Mellon Corp Raises Stock Holdings in AbbVie Inc. $ABBV - Zolmax

AbbVie Delivers 400% Returns Beating The S&P 500 by 139% - AOL

Top 5 High-Yield Dividend Stocks for Income Investors in 2026

This Is What a $1 Million Dividend Portfolio Pays After Taxes

The Bull Case For AbbVie (ABBV) Could Change Following EU Approval Of AQUIPTA For Acute Migraine

AbbVie Inc. $ABBV Stock Holdings Increased by BNP Paribas - Stock Observer

Revenue Rises 27.5%; AbbVie Pact Marks Key FY26 Milestone

COFG Advisors LLC Invests $4.09 Million in AbbVie Inc. $ABBV - Stock Observer

AbbVie (NYSE:ABBV) Shares Up 1.4% - Here's What Happened - Daily Political

Consensus meta-analysis of genome-wide association studies for Alzheimer's disease and related dementias

Clonal Hematopoiesis does not influence manufacturing of Chimeric Antigen Receptor (CAR) T-Cells

AbbVie (ABBV) to Attend Goldman Sachs Global Healthcare Conference

Johnson & Johnson Hopes to Dethrone AbbVie's Biggest Growth Driver. Here's Why Investors Shouldn't Panic - AOL

AbbVie Inc. (ABBV) Announces EC Authorization of Expanded Label for VENCLYXTO®

Is AbbVie Inc. (ABBV) Expanding Its Oncology Pipeline With New BPDCN Treatment Approval?

17,902 Shares in AbbVie Inc. $ABBV Purchased by COFG Advisors LLC

Glenmark Pharmaceuticals Ltd (BOM:532296) Q4 2026 Earnings Call Highlights: Strong Revenue ...

Access to CAR-T cell therapy in Central and Eastern Europe: persistent barriers and inequalities as of October/November 2025

Promising Pharmaceutical Stocks To Follow Now - June 1st - Zolmax

Natera And 2 Other Companies That May Be Trading Below Their Estimated Value

AbbVie Inc. $ABBV Shares Bought by Hillsdale Investment Management Inc.

AbbVie Inc. (NYSE:ABBV) Given Consensus Recommendation of "Moderate Buy" by Brokerages - Daily Political

Analysts Have Conflicting Sentiments on These Healthcare Companies: Krystal Biotech (KRYS), AbbVie (ABBV) and Tempus AI, Inc. Class A (TEM)

SEZ6-targeting antibody−drug conjugate ABBV-706 in advanced small cell lung cancer and solid tumors: a phase 1 trial

Privacy preserving digital platform for patient reported outcomes in inflammatory bowel disease

Botulinum Toxin Drugs Market Demand and Future Opportunities - Express Press Release Distribution

AbbVie Inc. $ABBV Shares Bought by MUFG Securities EMEA plc

Railway Pension Investments Ltd Has $196.44 Million Stock Holdings in AbbVie Inc. $ABBV - Stock Observer

AbbVie Inc. $ABBV Shares Sold by Welch & Forbes LLC - Stock Observer

AbbVie Inc. $ABBV Position Increased by MUFG Securities EMEA plc - Daily Political

Investment Analysts' Upgrades for May 30th (A, ABBV, ACA, AFCG, AKAN, ALLR, ALRS, ASUR, AXIA, BILL) - Stock Observer

SBI Okasan Asset Management Co.Ltd. Acquires New Shares in AbbVie Inc. $ABBV - Zolmax

Intech Investment Management LLC Sells 2,467 Shares of AbbVie Inc. $ABBV - Stock Observer

SBI Okasan Asset Management Co.Ltd. Buys New Holdings in AbbVie Inc. $ABBV - Daily Political

AbbVie (NYSE:ABBV) Raised to Strong-Buy at Wall Street Zen

Norges Bank Takes $5.87 Billion Position in AbbVie Inc. $ABBV - Daily Political

Eurizon Capital SGR S.p.A. Acquires Shares of 1,554,089 AbbVie Inc. $ABBV - Daily Political

AbbVie (ABBV) Expands Venclyxto Label for Chronic Lymphocytic Leukemia Treatment

VYM Climbs 26% In a Year While Its Core Dividend Payers Extend Their Streaks

AbbVie Stock: Is ABBV Outperforming the Healthcare Sector?

Rothschild Investment LLC Reduces Position in AbbVie Inc. $ABBV - Zolmax

AbbVie's VENCLYXTO Label Gets EU Approval For Chronic Lymphocytic Leukemia Treatment

Assessing AbbVie (ABBV) Valuation After FDA Approval Of Decnupaz For Ultra Rare Blood Cancer

Best Pharmaceutical Stocks To Research - May 29th - Daily Political

Savant Capital LLC Sells 22,942 Shares of AbbVie Inc. $ABBV

AbbVie Inc. $ABBV Shares Sold by FUKOKU MUTUAL LIFE INSURANCE Co

National Pension Service Sells 77,989 Shares of AbbVie Inc. $ABBV - Daily Political

AbbVie (NYSE:ABBV) Shares Up 1.5% - Here's What Happened - Zolmax

AbbVie (NYSE:ABBV) Stock Price Up 1.5% - Here's What Happened

Huntington National Bank Buys 17,446 Shares of AbbVie Inc. $ABBV

Is AbbVie (ABBV) Still Attractive After A 21.5% One Year Share Price Gain?

Genetic variation in antidiabetic drug targets: associations with Parkinson's disease risk and age at onset

Long-term outcomes of low-dose dasatinib in older patients with chronic myeloid leukemia in chronic phase: an extended follow-up of the DAVLEC phase 2 trial

AbbVie (ABBV) Receives FDA Approval for Groundbreaking BPDCN Treatment

Abbvie Gets FDA Approval for Blood Cancer Treatment | Morningstar

AbbVie announces FDA approval of DECNUPAZ

AbbVie (ABBV) Receives FDA Approval for Decnupaz in Rare Cancer Treatment

Ironwood Pharmaceuticals (IRWD) Gains FDA Approval for Linzess in Young Patients

AbbVie Inc. $ABBV Shares Bought by King Luther Capital Management Corp - Zolmax

Piper Sandler Raises Price Target on AbbVie (ABBV) Amid Strong IBD Pipeline Progress

Final Trades: AbbVie, Deckers and Goldman Sachs

34,517 Shares in AbbVie Inc. $ABBV Purchased by Seaview Investment Managers LLC - Zolmax

Fisher Asset Management LLC Buys 352,487 Shares of AbbVie Inc. $ABBV

MSH Capital Advisors LLC Boosts Holdings in AbbVie Inc. $ABBV

AbbVie Inc. $ABBV Holdings Raised by Fisher Asset Management LLC

Harbour Investments Inc. Purchases 146,611 Shares of AbbVie Inc. $ABBV - Stock Observer

Is EMA Backing For MAVIRET And Boey Reshaping The Investment Case For AbbVie (ABBV)?

MSH Capital Advisors LLC Increases Holdings in AbbVie Inc. $ABBV - Daily Political

Seaview Investment Managers LLC Acquires Shares of 34,517 AbbVie Inc. $ABBV - Daily Political